LP
SAGE

LMR Partners’s Sage Therapeutics SAGE Stock Holding History

LMR Partners’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-15,200
Closed -$313K – 1109
2023
Q3 		$313K Buy
+15,200
New +$439K ﹤0.01% 600
2021
Q2 		– Sell
-11,150
Closed -$835K – 1297
2021
Q1 		$835K Buy
+11,150
New +$914K 0.02% 521
2020
Q1 		– Sell
-78,720
Closed -$5.68M – 416
2019
Q4 		$5.68M Buy
78,720
+71,220
+950% +$8.76M 0.01% 75
2019
Q3 		$1.05M Buy
+7,500
New +$1.25M 0.05% 162
2018
Q4 		– Sell
-3,301
Closed -$466K – 465
2018
Q3 		$466K Sell
3,301
-62,723
-95% -$9.68M 0.03% 195
2018
Q2 		$10.3M Buy
+66,024
New +$10.4M 0.54% 30

Other funds holding SAGE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

LMR Partners's SAGE Position: Q4 2023 in Review

LMR Partners sold out of Sage Therapeutics (SAGE) in Q4 2023, closing a stake of 15,200 shares — an estimated $313K sold.

LMR Partners first reported a position in SAGE in Q2 2018 and held it in 6 quarters. The position peaked at $10.3M in Q2 2018. 201 funds tracked by Wall St. Rank hold SAGE as of Q4 2023.

  • LMR Partners reported no remaining Sage Therapeutics position as of Q4 2023 after selling out during the quarter.
  • LMR Partners sold 15,200 Sage Therapeutics shares in Q4 2023, an estimated $313K.
  • LMR Partners first reported a position in Sage Therapeutics in Q2 2018 and held it in 6 quarters.
  • LMR Partners's Sage Therapeutics position peaked at $10.3M in Q2 2018.
  • 201 funds tracked by Wall St. Rank held Sage Therapeutics as of Q4 2023.

Based on LMR Partners's 13F filing for Q4 2023, filed 14 Feb 2024.